Back to results
US 2022/0009901 A1Published application
Chemical compounds
AssigneeAstraZeneca AB
InventorsJEFFREY WALLACE JOHANNES, SUDHIR MAHADEO HANDE, AVIPSA GHOSH, XIAOLAN ZHENG, MARTIN PACKER, SEBASTIEN LOUIS DEGORCE
Life of this patent
Estimating the term…
Abstract
The present invention relates to azaquinolone compounds of Formula (I), and their use in medicine.
Claims35
A compound of Formula I
- wherein:
- R1 is independently selected from H, C1-4 alkyl, C3-6cycloalkyl, C1-4 fluoroalkyl, and C1-4 alkyloxy;
- R2 is independently selected from H, halo, C1-4 alkyl, and C1-4 fluoroalkyl;
- and
- R3 is H or C1-4 alkyl;
- R4 is halo or C1-4 alkyl,
- or a pharmaceutically acceptable salt thereof.
4 more elements
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.